2200 ⎘
Animals characterised by species; Mammal Primate
METHOD FOR PRODUCING NONHUMAN PRIMATE ANIMAL MODEL OF CEREBRAL INFARCTION AND PHARMACEUTICAL COMPOSITION FOR TREATMENT OF CEREBRAL INFARCTION
#2ANIMAL MODELS AND METHODS OF USE
#3ARTIFICIAL EXPRESSION CONSTRUCTS FOR SELECTIVELY MODULATING GENE EXPRESSION IN INTERNEURONS
#4PRIMATE DISEASE MODEL CONSTRUCTION METHOD BASED ON FAST GENE EDITION
#5ANIMAL MODELS, SCREENING METHODS, AND TREATMENT METHODS FOR INTRAOCULAR DISEASES OR DISORDERS
#6ARTIFICIAL EXPRESSION CONSTRUCTS FOR MODULATING GENE EXPRESSION IN NEURONS WITHIN THE THALAMUS
#7NON-HUMAN PRIMATE ALZHEIMER'S DISEASE MODEL ANIMAL AND METHOD FOR PRODUCING SAME
#8ANIMAL MODEL FOR NEURODEGENERATIVE DISORDERS
#9GENE EDITING TO CORRECT ANEUPLOIDIES AND FRAME SHIFT MUTATIONS
#10ARTIFICIAL EXPRESSION CONSTRUCTS FOR SELECTIVELY MODULATING GENE EXPRESSION IN SELECTED NEURONAL CELL POPULATIONS
#11Animal models, screening methods, and treatment methods for intraocular diseases or disorders
#12ARTIFICIAL EXPRESSION CONSTRUCTS FOR SELECTIVELY MODULATING GENE EXPRESSION IN INTERNEURONS
#13METHOD FOR FAST GENE EDITING AND CONSTRUCTING PRIMATE DISEASE MODEL
#14GENERATION OF A POPULATION OF HINDBRAIN CELLS AND HINDBRAIN-LIKE ORGANOIDS FROM PLURIPOTENT STEM CELLS
#15HUMAN GENE CORRECTION
#16Method for preparing non-human primate somatic cell cloned animal
#17Non-human primate restraint system
#18Recombinant HIV compositions and uses thereof in animal models
#19GENETICALLY MODIFIED CELLS, TISSUES, AND ORGANS FOR TREATING DISEASE
#20Method for producing acoustic trauma deafness model animal, and acoustic trauma deafness model animal produced by the same
#21Non-human primate model of age-related macular degeneration and method for producing same
#22ANIMAL MODEL FOR STUDYING COMPLEX HUMAN DISEASES
#23Sperm-Specific Cation Channel, and Uses Therefor
#24SPERM-SPECIFIC CATION CHANNEL, CATSPER4, AND USES THEREFOR
#25Autologous Mammalian Models Derived from Induced Pluripotent Stem Cells and Related Methods
#26Transgenic non-human animal comprising a mutant alpha-synuclein
#27Mutant alpha-synuclein, and methods using same
#28TRANSGENIC ANIMALS WITH CUSTOMIZABLE TRAITS
#29GENETICALLY STERILE ANIMALS
#30Biomarkers associated with autoimmune diseases of the lung
#31Chimeric avian-based screening system containing mammalian grafts
#32Establishment of rhesus monkey model of autoimmunity type 1 diabetes
#33Primate model from the family cercopithecidae infected by a HBV strain of human genotype
#34Sperm-specific cation channel, CatSper4, and uses therefor
#35Methods of Modulating Thrombocytopenia and Modified Transgenic Pigs
#36PREVENTION AND TREATMENT OF BLOOD COAGULATION-RELATED DISASES
#37Mutant alpha-synuclein, and methods using same
#38METHOD FOR EVALUATION OF DIFFERENTIATION ABILITY OF STEM CELL
#39Multipotent Adult Stem Cells, Sources Thereof, Methods of Obtaining and Maintaining Same, Methods of Differentiation Thereof, Methods of Use Thereof and Cells Derived Thereof
#40Methods for introducing a human gene into a marmoset embryo for making a transgenic marmoset
#41Prophylactic or therapeutic agent for diabetic maculopathy
#42METHODS FOR CORRECTING MITOTIC SPINDLE DEFECTS AND OPTIMIZING PREIMPLANTATION EMBRYONIC DEVELOPMENTAL RATES ASSOCIATED WITH SOMATIC CELL NUCLEAR TRANSFER IN ANIMALS
#43Therapeuting compositions comprising an RNAi agent and a neurotrophic factor and methods of use thereof
#44Identification of Genes and Their Products Which Promote Hybrid Vigour or Hybrid Debility and Uses Thereof
#45Animal Model With Induced Arrhythmia
#46Methods for identifying neuripotent cells
#47Sperm-specific cation channel, CatSper4, and uses therefor
#48Transgenic Mammals Expressing Human Preproinsulin
#49Reversibly immortalized mammalian liver cells and use thereof
#50Chimeric avian-based screening system containing mammalian grafts
#51METHODS FOR CORRECTING MITOTIC SPINDLE DEFECTS AND OPTIMIZING PREIMPLANTATION EMBRYONIC DEVELOPMENTAL RATES ASSOCIATED WITH SOMATIC CELL NUCLEAR TRANSFER IN ANIMALS
#52Construction of Arterial Occlusive Disease Animal Model
#53METHODS FOR CORRECTING MITOTIC SPINDLE DEFECTS ASSOCIATED WITH SOMATIC CELL NUCLEAR TRANSFER IN ANIMALS
#54Non-human primate embryonic stem and germ cells: methods of use and methods of making same
#55Model mouse of Alzheimer's disease expressing FAD APP 716 and use thereof
#56Prophylactic or therapeutic agent for diabetic maculopathy
#57Anti-migraine treatments
#58Method of Identifying Therapeutic Compounds Which Can Be Used for the Treatment and/or Prevention of Infections and Diseases Caused by Human Herpesviruses
#59Anti-migraine spirocycles
#60Spirocyclic anti-migraine compounds
#61Non-terminal method of identifying anti-migraine compounds
#62Method of differentiation from embryo-stem cell of primate to hematogenous cell
#63Method of preparing transgenic organism with use of methylation and system therefor
#64Animal model systems for viral pathogenesis of neurodegeneration, autoimmune demyelination, and diabetes
#65Sperm-specific cation channel, catsper-4, and uses therefor
#66Expression system for stem-loop rna molecule having rnai effect
#67Methods for correcting mitotic spindle defects and optimizing preimplantation embryonic developmental rates associated with somatic cell nuclear transfer in animals
#68In vivo animal model of human leukemia
#69Multipotent adult stem cells, sources thereof, methods of obtaining and maintaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof
#70Cloning of rhadinovirus genome and methods for its use
#71Modulation of brain pathways and function
#72Method of constructing spinal injury model monkey and utilization thereof
#73RhPV as a model for HPV-induced cancers
#74Cloning using donor nuclei from differentiated fetal and adult cells
#75Method of enucleation and oocyte activation in somatic cell nuclear transfer in primates